Immunotherapy for colorectal cancer: where are we heading?-Reference-Cited by-同舟云学术

Immunotherapy for colorectal cancer: where are we heading?

Published:2017-04-13 Issue:6 Volume:17 Page:709-721
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Basile Debora,Garattini Silvio Ken,Bonotto Marta,Ongaro Elena,Casagrande Mariaelena,Cattaneo Monica,Fanotto Valentina,De Carlo Elisa,Loupakis Fotios,Urbano Federica,Negri Francesca V.,Pella Nicoletta,Russano Marco,Brunetti Oronzo,Scartozzi Mario,Santini Daniele,Silvestris Nicola,Casadei Gardini Andrea,Puzzoni Marco,Calvetti Lorenzo,Cardarelli Nadia,Aprile Giuseppe

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1315405

Reference95 articles.

1. Global patterns and trends in colorectal cancer incidence and mortality

2. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

3. The predictive value ofKRAS, NRAS, BRAF, PIK3CAand PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis

4. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin-shellac nanoparticle-loaded GelMA/SilMA hydrogel for colorectal cancer therapy;European Journal of Pharmaceutics and Biopharmaceutics;2024-09

2. The Tumor Microenvironment Mediates the HIF-1α/PD-L1 Pathway to Promote Immune Escape in Colorectal Cancer;International Journal of Molecular Sciences;2024-03-27

3. Advances in reprogramming of energy metabolism in tumor T cells;Frontiers in Immunology;2024-02-13

4. The Potential Role of Intestinal Stem Cells and Microbiota for the Treatment of Colorectal Cancer;Advances in Experimental Medicine and Biology;2024

5. Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer;Journal for ImmunoTherapy of Cancer;2023-10